Currently Viewing:
Currently Reading
What We're Reading: Is the GOP Eyeing Changes to Medicare, Too?
January 04, 2017 – AJMC Staff
What We're Reading: Drug Makers Take Cautious Approach on Off-Label Promotion
January 02, 2017 – AJMC Staff
Biggest Healthcare Story of 2016: Readers Weigh In
January 02, 2017 – Christina Mattina
Infographic: Making Sense of MACRA
December 31, 2016 – Laura Joszt
Readmission Rates Declined After HRRP, Especially for Low-Performing Hospitals
December 29, 2016 – Christina Mattina
What We're Reading: W.Va. Sues Drug Distributors for Fueling the Opioid Epidemic
December 28, 2016 – AJMC Staff
What We're Reading: Medicare Cracks Down on Antibiotic-Resistant Infections in Hospitals
December 26, 2016 – AJMC Staff
ACA vs Obamacare: Search Interest in 2016
December 24, 2016
This Week in Managed Care: December 23, 2016
December 23, 2016

What We're Reading: Is the GOP Eyeing Changes to Medicare, Too?

AJMC Staff
What we're reading, January 4, 2017: Republicans in Congress may also make changes to Medicare; churches and faith-based organizations launch syringe exchanges; and judge rules Amgen's PCSK9 patent is valid.
Repealing and replacing Obamacare is definitely on the list for Republican lawmakers, and so is a possible privatization of veterans’ medical care, and even an overhaul of Medicaid. Now, the Miami Herald is reporting that Medicare could also face changes from the Republican-controlled Congress. House Speaker Paul Ryan (R-WI) has been a proponent of moving to a voucher system in Medicare. Others like the idea of subsidies to purchase private plans. Democrats will fight moves to change Medicare, and they may have an unlikely ally in President-elect Donald J. Trump, who said on the campaign trail that he wouldn’t change retirement programs like Social Security and Medicare.

Churches and faith-based organizations that have supported syringe exchange programs sometimes launch their own. These programs are useful in combatting the opioid epidemic and the spread of diseases like HIV and hepatitis C. According to STAT, there are no hard numbers, but more and more faith-based organizations are becoming directly involved in syringe exchanges and running them along with soup kitchens, temporary shelters, and other outreach ministries.

Sanofi and Regeneron lost their bid to overturn a verdict upholding 2 Amgen patents related to the cholesterol drug Repatha. A federal judge refused to throw out a court verdict from March that found Amgen’s patents valid, reported Reuters. Amgen brought the lawsuit in October 2014, claiming Praluent, sold by Sanofi and Regeneron, infringed on Amgen’s patents related to the PCSK9 protein. Damages have yet to be set and the presiding judge has to decide if she will block Sanofi and Regeneron from selling Praluent. Sanofi and Regeneron plan to appeal.

Copyright AJMC 2006-2020 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
Welcome the the new and improved, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up